CAMBRIDGE, England--(BUSINESS WIRE)--University of Cambridge, Genomics England Ltd., and Illumina, Inc. (NASDAQ:ILMN) today announced the start of a three-year project that will sequence 10,000 whole genomes of children and adults with rare genetic diseases. The project represents a pilot for Genomics England Ltd., which will provide 2,000 samples, and marks the beginning of the national endeavor to sequence 100,000 genomes in the UK National Health Service (NHS), announced recently by the Prime Minister, David Cameron.
Help employers find you! Check out all the jobs and post your resume.
